Stay updated on CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Sign up to get notified when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.
Latest updates to the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedCore study information such as design, eligibility criteria, primary and secondary outcomes, and locations remains unchanged; only minor UI/layout differences are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check20 days agoChange DetectedPage revision label updated from v3.3.1 to v3.3.2 in the header/footer; no study content or data were changed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check28 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed; there is no visible change to the study details or user-facing features.SummaryDifference0.1%
- Check35 days agoChange DetectedFunding-status banner about government lapse was removed from the Study Details page; this administrative notice did not affect the core study information.SummaryDifference0.5%
- Check42 days agoChange DetectedNo additions or deletions were detected; the Study Details page content, including status, locations, and eligibility criteria, remains unchanged.SummaryDifference0.1%
- Check49 days agoChange DetectedLast update date refreshed and minor wording edits were made; core study details (eligibility, intervention, outcomes) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
Stay in the know with updates to CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.